Succinimide

Succinimide

SCHEMBL6522318

CC(C)(C)OC(=O)NCCCC[C@H](NC(=O)OC(C)(C)C)C(=O)O.O=C1CCC(=O)N1

nearest known ligand 0.51

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 3/20 0.51
KMT2A Q03164 3/20 0.51
GAA P10253 1/20 0.51
ALDH1A1 P00352 1/20 0.48
TSHR P16473 1/20 0.48
ACE P12821 1/20 0.47
TDP1 Q9NUW8 6/20 0.46
ATM Q13315 2/20 0.46
NPSR1 Q6W5P4 3/20 0.45
POLB P06746 2/20 0.45
MAPT P10636 2/20 0.44
CXCR3 P49682 1/20 0.43
CTSS P25774 1/20 0.43
CTSK P43235 1/20 0.43
SIRT5 Q9NXA8 1/20 0.43
KLK7 P49862 1/20 0.42
KLK5 Q9Y337 1/20 0.42
CA1 P00915 2/20 0.42
CA2 P00918 2/20 0.42
IDO1 P14902 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3445777 0.88 MEN1 (0.65) MEN1KMT2AGAAALDH1A1TSHR
SCHEMBL10241524 0.88 MEN1 (0.65) MEN1KMT2AGAAALDH1A1TSHR
SCHEMBL391537 0.88 MEN1 (0.65) MEN1KMT2AGAAALDH1A1TSHR
Hydrochloric Acid SCHEMBL28881882 0.86 MEN1 (0.63) MEN1KMT2AGAAALDH1A1TSHR
SCHEMBL21702752 0.86 MEN1 (0.63) MEN1KMT2AGAAALDH1A1TSHR
Hydrochloric Acid SCHEMBL28881885 0.86 MEN1 (0.63) MEN1KMT2AGAAALDH1A1TSHR
SCHEMBL12238298 0.84 MEN1 (0.71) MEN1KMT2AGAAALDH1A1TSHR
SCHEMBL4888105 0.84 MEN1 (0.71) MEN1KMT2AGAAALDH1A1TSHR
SCHEMBL903957 0.84 MEN1 (0.71) MEN1KMT2AGAAALDH1A1TSHR
SCHEMBL13702219 0.83 MEN1 (0.58) MEN1KMT2AGAAALDH1A1TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120196933-A1 MEXILETINE PRODRUGS FRANKLIN RICHARD (GB) 2012-08-02 US disclosed
US-20110028552-A1 MEXILETINE AMINO ACID AND PEPTIDE PRODRUGS AND USES THEREOF SHIRE LLC 2011-02-03 US disclosed
US-6410680-B1 STRESS RESISTANCE THERAPY DENDRIMOLECULAR, INC. 2002-06-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120196933-A1 MEXILETINE PRODRUGS SLC16A1, MTPN, SLC16A3 MEN1 80/4885KMT2A 804/4885GAA 462/4885
US-20110028552-A1 MEXILETINE AMINO ACID AND PEPTIDE PRODRUGS AND USES THEREOF VIP, TRPV1, LNPEP MEN1 604/4885KMT2A 418/4885GAA 2035/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.